Global Personalized Medicine (PM) Solution Market Research Report 2022

Market Analysis and Insights: Global Personalized Medicine (PM) Solution Market
The global Personalized Medicine (PM) Solution market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Personalized Diagnostics accounting for % of the Personalized Medicine (PM) Solution global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Personalized Medicine (PM) Solution market size is valued at US$ million in 2021, while the North America and Europe Personalized Medicine (PM) Solution are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Personalized Medicine (PM) Solution landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Medicine (PM) Solution market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Medicine (PM) Solution market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Medicine (PM) Solution market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Medicine (PM) Solution market.
Global Personalized Medicine (PM) Solution Scope and Market Size
Personalized Medicine (PM) Solution market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Personalized Medicine (PM) Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Personalized Diagnostics
Personalized Therapies
Personalized Nutrition & Wellness

Segment by Application
Oncology
Neurosciences
Immunology
Respiratory
Others

By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
2bPrecise
OneOme
TIGAR Health- IR2Dx
Kailos Genetics
Syapse Inc
Karius
Astarte Medical
Fabric Genomics, INC.
Orion Health
2B Precise
Fabric Genomics
Pfizer
Gene 42
IBM Watson Health
Philips Healthcare
Medtronic
Nanthealth
Navican
N-of-One
PierianDx
Sunquest Information System
Tempus
Novartis
Translational Software
Biocrates Life Sciences AG
Nanostring Technologies
Thermo Fisher Scientific
Quest Diagnostics Incorporated